A New Broad Range Plasmid for DNA Delivery in Eukaryotic Cells Using Lactic Acid Bacteria: In Vitro and In Vivo Assays
Lactococcus lactis is well documented as a promising candidate for development of novel oral live vaccines. It has been broadly engineered for heterologous expression, as well as for plasmid expression vector delivery, directly inside eukaryotic cells, for DNA vaccine, or as therapeutic vehicle. Thi...
Main Authors: | Pamela Mancha-Agresti, Mariana Martins Drumond, Fillipe Luiz Rosa do Carmo, Monica Morais Santos, Janete Soares Coelho dos Santos, Franco Venanzi, Jean-Marc Chatel, Sophie Yvette Leclercq, Vasco Azevedo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-03-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050116301383 |
Similar Items
-
Effect of Medium Formulation and Culture Condition on Growth and Plasmid Stability of Recombinant Lactococcus Lactis AM3
by: Ho, Hooi Ling
Published: (2002) -
Novel Strategies for Efficient Production and Delivery of Live Biotherapeutics and Biotechnological Uses of Lactococcus lactis: The Lactic Acid Bacterium Model
by: Laísa M. Tavares, et al.
Published: (2020-11-01) -
Isolation and Characterisation of a Lactococcal Plasmid and Preliminary Construction of a Lactococcus - E. Coli Shutile Vector
by: Rizlan Ross, Ernie Eileen
Published: (2001) -
Plasmid Replicons for the Production of Pharmaceutical-Grade pDNA, Proteins and Antigens by <i>Lactococcus lactis</i> Cell Factories
by: Sofia O.D. Duarte, et al.
Published: (2021-01-01) -
Recombinant Invasive Lactococcus lactis Carrying a DNA Vaccine Coding the Ag85A Antigen Increases INF-γ, IL-6, and TNF-α Cytokines after Intranasal Immunization
by: Pamela Mancha-Agresti, et al.
Published: (2017-07-01)